$AWHL SEC Filings

Filed On	Filing
02 Oct 2026	Form 4: Strahley John, Chief Financial Officer Granted 97,417 Employee Stock Option (Right to Buy)
14 Aug 2026	10-Q
17 Jul 2026	Form 4/A: Strahley John, Chief Financial Officer Granted 70,000 Employee Stock Option (Right to Buy)
15 Jul 2026	Form 4: Strahley John, Chief Financial Officer Granted 75,000 Employee Stock Option (Right to Buy)
15 Jul 2026	Form 3: Strahley John, Chief Finacial Officer No securities owned
15 Jul 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
07 Jul 2026	8-K/A: Departure/Election of Directors or Officers; Compensation THIS SEPARATION AGREEMENT AND GENERAL RELEASE (the “Agreement and General Release”) is made and entered into on June 27, 2026, by and between Michael Buhle (“Executive”) and Aspira Women’s Health Inc., a Delaware corporation (the “Compan...
22 Jun 2026	D
22 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation
17 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
11 Jun 2026	SCHEDULE 13D/A
09 Jun 2026	Form 4: Schuler Jack W, 10% owner Bought 222,222 shares ($100K) · Acquired 300,000 Warrant (Right to Buy) (Open Market Purchase)
09 Jun 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
29 May 2026	DEFA14A
29 May 2026	Form 4: cohen Jeffrey k, Director Acquired 11,112 shares (Other Transaction) ($5K)
29 May 2026	Form 4/A: Fraser John D, Director Bought 16,389 shares ($7.38K) · Acquired 12,292 Warrant (Right to Buy) (Open Market Purchase)
29 May 2026	Form 4/A: cohen Jeffrey k, Director Bought 55,556 shares ($25K) · Acquired 41,667 Warrant (Right to Buy) (Open Market Purchase)
26 May 2026	8-K: Entry into a Material Definitive Agreement
15 May 2026	10-Q
30 Apr 2026	8-K: Departure/Election of Directors or Officers; Compensation

Comments